Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 41-60 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 41 | Northwood Space mediumweak | Opp 6 Risk 4 | Thesis: Northwood Space has one of the cleaner opportunity setups in this screen because the reviewed sources membership rationale says it raised $100 million in a notable space startup funding deal, which can matter over a 1 year+ horizon by extending development and commercialization runway. Why now: The rationale references article: and states Northwood Space raised $100 million in a notable spacetech funding deal; that size of financing is plausibly durable over a 1 year+ horizon, though recency cannot be fully validated from the absent article body. Caveats: No representative article or provided in the visible evidence body. No direct evidence after recent evidence window are exposed despite the positive rationale. Funding alone does not prove technical or commercial execution. |
| 42 | Orbital Inc. mediummedium | Opp 6 Risk 5 | Thesis: Orbital has a credible long-horizon opportunity signal because it was reported as having closed funding to verify a space-based data center concept, which supports continued development of an AI satellite constellation concept as of April 14, 2026. Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning Evidence
Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 43 | Redwire Corporation mediummedium | Opp 6 Risk 3 | Thesis: Redwire has the strongest opportunity evidence in this screen because the reviewed sources includes dated within the recent evidence window article context for both a June 4, 2026 contract from Astrobiome Space to launch the inaugural mission in the world’s first commercial space greenhouse on the ISS and an April 8, 2026 article listing Redwire among the Andromeda awardees. Together, these point to activity across both commercial in-space applications and national-security space programs over a 1 year+ horizon. Why now: The why-now case is the best in the set: a published June 4, 2026 article says Redwire was awarded a contract from Astrobiome Space for the inaugural flight of its commercial space greenhouse on the ISS. Earlier, on April 8, 2026, Defense Daily reported Redwire among companies awarded more than $1.8 billion total under the Andromeda SDA contracts. Those dated items suggest current business momentum that could matter over a 1 year+ horizon. Evidence
Caveats: Evidence is weak-context/supporting article context, not direct positive events. The standard-journal article carrying similar June 4, 2026 text is undated in the reviewed sources and should not be treated as independent confirmation. No material adverse evidence is available, but absence of negative evidence is not proof of low risk. |
| 44 | Scout Space mediummedium | Opp 6 Risk 4 | Thesis: Scout Space has credible growth-stage opportunity from a newly announced Series A financing and stated manufacturing expansion, which could support scaling of SDA sensors and software over a 1 year+ horizon. Why now: A dated May 6, 2026 article says Scout raised up to $18 million Series A and will use the capital for mission execution and expansion of manufacturing capabilities, creating a current capacity-building milestone for the next year, May 6, 2026). Evidence
Caveats: Most available support is weak context/supporting article context rather than direct positive events. Blue Origin partnership articles are from 2025 and were outside the 90-day recent evidence window, so they should not drive recency-based ranking |
| 45 | SES mediummedium | Opp 6 Risk 2 | Thesis: SES has the strongest current opportunity setup in this screen because within the recent evidence window dated evidence says SES was selected as a prime contractor in the U.S. Space Force Protected Tactical Satcom-Global program, with a combined $437.7 million award for SES and Viasat to each build and operate a satellite. That indicates current government program relevance with potential multiyear strategic value. Why now: The key evidence is recent and within the recent evidence window: a June 11, 2026 SpaceNews article says SES was selected last month as a prime contractor under the PTS-G program, with K2 Space providing SES's satellite platform Evidence
Caveats: Reviewed evidence is still supporting article context rather than a direct company filing. The Impulse transportation agreement is older and outside the 90-day recent evidence window. |
| 46 | Starcloud mediummedium | Opp 6 Risk 4 | Thesis: Starcloud is the strongest opportunity candidate in this screen because recent dated article context indicates capital raised and incremental network buildout steps for its orbital data center concept. A March 30, 2026 article says Starcloud raised $170 million at a $1.1 billion valuation. A later May 26, 2026 article says Starcloud announced a contract for more than 50 Starlink Mini Lasers to equip at least 25 satellites and use Starlink as a global data-relay network. A June 10, 2026 article further describes Starcloud as having raised about $200 million to date for a proposed constellation of 88,000 orbital data centers. Why now: Within the 90-day recent evidence window, Starcloud has the clearest sequence of dated business-state updates: funding on March 30, 2026, network-equipment contract on May 26, 2026, and additional context on capital raised and market positioning on June 10, 2026, For a 1 year+ horizon, that sequence supports an active buildout story even though evidence quality is not fully direct. Evidence
Caveats: All usable evidence is supporting article context; the reviewed sources provide no direct positive or negative dated event/facts. Repeated Starcloud claims across articles are not independent confirmation under the evidence standard. Opportunity and risk both remain dependent on future execution over a long horizon. |
| 47 | Synspective mediummedium | Opp 6 Risk 3 | Thesis: Synspective has the strongest opportunity evidence in this screen because multiple within the recent evidence window dated article-context items point to operational and strategic scaling: a May 1, 2026 article says Rocket Lab launched Synspective's ninth StriX SAR satellite, improving its ability to deliver persistent Earth observation capabilities; a June 3, 2026 press release says Synspective and KSAT expanded their strategic alliance to support constellation expansion; and a May 21, 2026 company page describes an operating fleet, SAR data sales, and solution services for government and commercial customers Why now: The recency stack is favorable for a 1 year+ thesis: May 1, 2026 launch progress, May 21, 2026 operating-profile context, and June 3, 2026 alliance expansion together suggest that constellation buildout and service-capability scaling were active in the most recent recent evidence window period Evidence
Caveats: Evidence is supporting article context and mostly neutral-polarity in reviewed sources structure, not direct dated event/facts. Two key supportive items are company-sourced pages/press releases. No retained adverse evidence exists, but absence of bad news is not proof of low risk. |
| 48 | UNASTELLA Corporation mediummedium | Opp 6 Risk 3 | Thesis: Recent article context says UNASTELLA raised $24 million to develop its own launch vehicles and engines, a meaningful capital-and-capability milestone for a rocket startup with potential multi-year product development relevance. Why now: The funding context is dated June 1, 2026 and sits well within the 90-day recent evidence window, making it recent enough to support a 1 year+ development runway thesis. Source date: June 1, 2026 Evidence
Caveats: Evidence is from a LinkedIn space briefing and is supporting article context only. No direct product milestone, customer, or contract evidence is available. |
| 49 | Vast Space mediummedium | Opp 6 Risk 4 | Thesis: Vast Space has the strongest opportunity profile in this screen because within the recent evidence window dated article context indicates a strategic expansion from commercial space stations into satellite manufacturing through a new high-power satellite bus line, with one article saying the new line targets communications, Earth observation, national security, and orbital data center constellations, and another saying Vast already has a customer. This product-line expansion can matter over a 1 year+ horizon if it broadens revenue sources beyond stations, May 19, 2026, May 19, 2026). Why now: The timing case is stronger than peers because the product expansion articles are dated May 19, 2026 and May 20, 2026, within the 90-day recent evidence window, and represent a potentially durable strategic change: moving into satellite buses rather than remaining only a station developer, May 19, 2026, May 20, 2026). Evidence
Caveats: Retained evidence is weak context supporting article context; there are no direct positive event/facts available. The March 2026 financing articles are outside the 90-day recent evidence window and cannot be primary support, even though they appear in representative articles. Several retained rows summarize the same basic product announcement and should not be treated as independent confirmation. |
| 50 | Voyager Space mediummedium | Opp 6 Risk 3 | Thesis: Voyager Space has the strongest reviewed sources-supported opportunity because within the recent evidence window it has dated evidence of a $16.5 million DARPA Phase 2 contract and dated company context showing electric propulsion capabilities for satellite constellations and broader space technologies, supporting a durable defense-space revenue and capability narrative over a 1 year+ horizon Why now: The timing is comparatively favorable: Voyager has dated within the recent evidence window evidence published May 26, 2026 for a $16.5M DARPA Phase 2 contract, May 29, 2026 defense/national security capability context, and June 4, 2026 current company capability context, all within the reviewed sources recent evidence window and relevant to a 1 year+ horizon Evidence
Caveats: Much of the evidence is supporting article context rather than direct positive rows. Some cited capability pages are company-provided materials. Ticker is absent in the required company entry even though external articles reference NYSE: VOYG; this output preserves the required ticker field from the input. |
| 51 | Xoople mediummedium | Opp 6 Risk 4 | Thesis: Recent large Series B financing to build an AI-powered Earth mapping constellation supports a medium-strength long-horizon scaling opportunity. Why now: Xoople closed a $130 million Series B on April 6, 2026/07 and articles say the capital is for building out its constellation; for a 1 year+ horizon, that financing can enable product and deployment progress, but the same dated coverage warns the market has historically been hard to monetize. Evidence
Caveats: Positive support is mostly supporting article context rather than positive evidence. Commercialization warning is article context, not a company-specific deterioration event. No direct customer, backlog, or launch milestone evidence is available. |
| 52 | Aalyria Technologies mediumweak | Opp 5 Risk 2 | Thesis: Aalyria Technologies appears attractive on reviewed sources evidence because it is directly included among awardees in U.S. Space Force Golden Dome contracts, a durable government-program signal that can matter over a 1 year+ horizon. Why now: Current relevance is tied to the cited Space Force Golden Dome contract award context in article, though the reviewed sources omits the and representative article details. Caveats: No article is supplied for the cited support article. Opportunity rests on a single contract-related rationale summary. Contract inclusion alone does not reveal contract size, economics, or conversion pace. |
| 53 | Aavuus mediummedium | Opp 5 Risk 3 | Thesis: Aavuus has the strongest recent opportunity setup in this screen because a dated article says it raised pre-seed funding and is building a global laser-based tracking network for debris tracking and collision avoidance in LEO, indicating financing plus product/infrastructure development in orbital safety and space domain awareness. Why now: The opportunity is timely because the retained article is dated June 9, 2026 and describes a current financing and product build phase rather than stale background context. That said, recency comes from source date/article date, and evidence grounding is still article-level rather than direct fact/events., June 9, 2026 Evidence
Caveats: Evidence is weak context and supporting article context, not direct structured positive event evidence. No explicit customer, contract, revenue, or regulatory milestone is cited. Same article appears in multiple rows and is not independent confirmation. |
| 54 | Astroscale lowweak | Opp 5 Risk 3 | Thesis: The reviewed sources states Astroscale focuses on satellite repair, refueling, and debris removal, and partnered with SKY Perfect JSAT for on-orbit satellite services. That indicates strategic positioning in an emerging service layer with potentially durable 1 year+ relevance. Why now: Why now is relatively constructive because a named partnership for on-orbit services can matter over a long strategic horizon, but exact timing and materiality cannot be validated from the reviewed sources because only membership rationale is visible. Caveats: Membership rationale references article ID: but the reviewed sources provide no or article summary. Relation counts are present in support metadata, but relations are context-only unless separately policy-gated. No direct positive or negative evidence arrays are populated. |
| 55 | CesiumAstro lowweak | Opp 5 Risk 3 | Thesis: Among the covered names, CesiumAstro has the clearest positive business context: an external article summary states it raised a $270M Series C round, bringing total funding to $655M, and provides communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms, suggesting better capitalization and broad platform relevance if that financing remains available to drive growth Why now: There is no fresh catalyst inside the 90-day evidence window. The visible article was published on February 14, 2026 and is outside the cutoff date of March 29, 2026, so it is useful as background but weak for recency-sensitive ranking Evidence
Caveats: The visible positive article is outside the 90-day recent evidence window cutoff and was dropped from reviewed evidence. External supporting source context is allowed as evidence context but is not merged into primary data source. |
| 56 | constellr mediummedium | Opp 5 Risk 2 | Thesis: Constellr has the best supported long-horizon opportunity in this screen. A dated article published April 16, 2026 says constellr operates a proprietary satellite constellation for thermal intelligence, launched its first satellite in January 2025, and closed a €37 million Series A in February 2026, which together indicate product deployment plus fresh capital to scale over a 1 year+ horizon. Why now: Why now is relatively strongest here because the retained evidence is within the 90-day recent evidence window and dated April 16, 2026, summarizing recent business-state milestones including a first satellite launch in January 2025 and a Series A closed in February 2026. Evidence
Caveats: Evidence is external article context, not a direct company filing or contract announcement. |
| 57 | Eycore mediumweak | Opp 5 Risk 3 | Thesis: Eycore has a modest opportunity signal because a dated May 2026 article says it launched Eycore-1, its first Earth observation satellite equipped with the company's SAR technology. A first in-orbit asset can be strategically important over a 1 year+ horizon if it enables product validation and future commercial traction. Why now: Why now is the dated first-satellite launch article from May 5, 2026, which is recent within the 90-day recent evidence window and relevant to a long-horizon de-risking story, though still early-stage. Evidence
Caveats: Evidence is supporting article context only, not a stronger structured positive event row. Single-article universe limits corroboration. No financing, customer, revenue, or performance follow-through evidence is provided. |
| 58 | Guodian Gaoke lowweak | Opp 5 Risk 2 | Thesis: Reviewed evidence rationale says Guodian Gaoke received the first trial license for satellite IoT services and that Tianqi low-orbit IoT constellation Phase I is complete. A completed initial constellation phase plus first-trial-license status is one of the better long-horizon setup signals in this otherwise thin-evidence batch. Why now: The why-now would be the reported trial license and completed Phase I constellation, but the reviewed sources does not provide the underlying article summary or date-specific evidence for stronger timing confidence. Caveats: Phase2 membership rationale references: but no summary/evidence row is available to cite directly. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Score exceeds Beijing Guodian High-Tech slightly because rationale mentions both licensing and constellation completion. |
| 59 | Interlune lowweak | Opp 5 Risk 3 | Thesis: The reviewed sources membership rationale states Interlune won a $6.9M NASA contract for lunar resource development with a payload for lunar regolith volatiles and extraction demonstrations. For a 1 year+ horizon, that is a concrete external validation event that could support technology maturation and future lunar-resource positioning. Why now: The key 'why now' is the cited NASA contract in article: but the reviewed sources does not include the article summary or, so exact date and latest status are not visible here. Caveats: Opportunity case relies on membership rationale rather than included direct article evidence. A $6.9M contract is positive validation, but contract size alone may not be enough to de-risk a lunar-resource business. No negative evidence is provided, so risk mostly reflects execution uncertainty. |
| 60 | Iridium Communications Inc. lowmedium | Opp 5 Risk 3 | Thesis: Iridium has a moderate long-horizon opportunity case from current evidence that it operates a 66-satellite LEO constellation providing global mobile satellite communications, a durable strategic asset position if demand remains resilient. Why now: The current support is an April 3, 2026 article-level overview of Iridium’s constellation and service footprint rather than a new event, so timing fit is only medium. Evidence
Caveats: Evidence is supporting article context, not a fresh contract or earnings-linked milestone. |
Risk view
Showing rows 21-40 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 21 | Capella Space highstrong | Opp 8 Risk 4 | Thesis: Risk is present but not thesis-dominant: Capella is undertaking defense-oriented prototype work and broader strategic expansion beyond commercial SAR, which can carry execution complexity, but the reviewed sources contain no direct adverse evidence within the recent evidence window. Why now: The April 8, 2026 SDA award is recent within the recent evidence window and is directly relevant to a 1 year+ horizon because it funds spacecraft design and development for a government demonstration program. Later context articles in April-June 2026 continue to depict Capella as an operating SAR platform with defense exposure. Evidence
Caveats: The positive contract evidence is classified as a neutral supporting fact in the reviewed sources, so direction is inferred from the business substance rather than explicit positive polarity labeling. Several contextual articles mention a planned acquisition or subsidiary status, but time-sensitive ownership/public-status interpretations should be treated cautiously because not all such references are direct, dated transaction-closing evidence. For example, and |
| 22 | Cowboy Space mediummedium | Opp 7 Risk 4 | Thesis: Execution risk is meaningful because the business combines new rocket development with orbital data-center infrastructure, and one cited article says the first launch is expected before the end of 2028, implying a long path from capital raise to operational proof. Why now: Multiple dated articles on May 11, 2026 report Cowboy Space raised $275 million in Series B financing at a $2 billion valuation to build rockets with orbital data-center upper stages, and a TechCrunch article says the company is standing up its own rocket program with a first launch expected before end-2028 Evidence
Caveats: The reviewed sources contain no explicit negative event evidence; risk is inferred from execution complexity and long timeline, not from adverse events. Several supporting rows repeat the same May 11, 2026 financing story and are not independent confirmation. Some supporting article context is undated and should be treated cautiously for recency. |
| 23 | Eutelsat Communications SA mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the ranking payload contains no kept direct evidence or representative articles for those claims, so the thesis depends on membership-support statements without available article detail, economics, or recency granularity beyond inclusion in the recent evidence windowed reviewed sources. Why now: The reviewed sources' membership rationale cites current program/contract relevance through support articles 2026-04, and: but were not provided in the payload, limiting precise timing narration. Evidence
Caveats: The reviewed sources does not provide for the membership-support article IDs. Opportunity score is tempered by the absence of kept direct evidence in the ranking payload. |
| 24 | GalaxEye mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the reviewed sources does not provide direct evidence of post-launch operational performance, customer revenue conversion, or successful scaling beyond the first satellite. Funding references are inconsistent across articles, and planned next-round financing after commissioning indicates continued capital dependence. Why now: The key timing change is that earlier pre-launch coverage from April 23, 2026 was followed by launch coverage on May 3, 2026/May 4, 2026, and later June 16, 2026 context states the first satellite was launched in May 2026, confirming a business-state transition from concept/pre-launch to deployed asset status. The NSIL resale agreement was reported earlier on February 13, 2026, giving a potential go-to-market bridge once satellite data is available. Evidence
Caveats: Most reviewed sources rows are neutral facts or supporting article context rather than explicit positive evidence. Funding totals vary across articles (~$14.5M, $18.3M, ~$20M), so exact capitalization is uncertain |
| 25 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Risk is moderate because evidence coverage is absent inside the 90-day recent evidence window, making business-state, ownership, and catalyst timing uncertain for a 1 year+ ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 26 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: Risk is somewhat higher than opportunity because launch development is technically demanding and capital intensive, and the reviewed sources provide no available direct event evidence beyond the membership rationale to confirm de-risking milestones within the recent evidence window. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 27 | Impulse Space mediummedium | Opp 8 Risk 4 | Thesis: Main risk is execution risk after a very large private financing round: the reviewed sources confirms capital raised, but does not provide within the recent evidence window direct evidence of completed commercial deployments or revenue realization. The article context says valuation was undisclosed, adding some uncertainty around terms and expectations. Why now: The catalyst is recent and dated: on June 2, 2026/June 3, 2026, Impulse Space disclosed a $500 million Series D and total capital raised above $1 billion, which is highly relevant for a 1 year+ scaling thesis. Evidence
Caveats: Some supportive items are supporting article context and should not be treated as independent confirmation if repeating the same financing announcement. Older commercial contract and government contract references in representative articles are outside the 90-day recent evidence window and therefore not primary recency support here. |
| 28 | Impulse Space lowweak | Opp 4 Risk 4 | Thesis: Risk is not based on direct adverse evidence; instead it reflects defense-program execution uncertainty and lack of currently available corroboration for program status, milestones, or revenue conversion, unavailable in reviewed sources). Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking. Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence. |
| 29 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Risk is also elevated because the same recent context ties the thesis to a near-term launch outcome and milestone execution; the opportunity appears highly contingent on launch success, making binary execution risk material over a 1 year+ horizon. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 30 | ispace lowweak | Opp 3 Risk 4 | Thesis: Reviewed evidence rationale explicitly notes this is ispace's 'second attempt after 2023 failure,' which raises meaningful execution risk for a mission-driven thesis. With no direct positive or negative reviewed evidence, the prior failure context remains the clearest directional risk indicator in the reviewed sources. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 31 | Logos Space Services mediummedium | Opp 6 Risk 4 | Thesis: The same evidence implies substantial execution and engineering risk because the planned network is very large and would use higher-frequency K-, Q- and V-band spectrum that can improve capacity but also pose engineering challenges. Why now: A dated article within the 90-day recent evidence window, with based on April 13, 2026, states that Logos Space Services recently secured FCC approval for a constellation of up to 4,178 broadband satellites and described both target customers and technical architecture, making this a timely strategic-development signal for a 1 year+ horizon. Evidence
Caveats: Evidence is supporting article context, not a richer set of direct dated events/facts. Only one article after recent evidence window; same-article repeated rows are not independent confirmation. |
| 32 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Risk remains moderate because the reviewed sources only provides supporting article context, not direct contract economics, scope allocation to Millennium, or follow-on execution milestones. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 33 | NewOrbit Space mediummedium | Opp 4 Risk 4 | Thesis: Risk is also meaningful because the evidence is undated supporting article context, so recency is uncertain; for a business-state claim like financing and current program maturity, lack of date makes it harder to assess whether the capital raise is still a live catalyst or already absorbed. Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated Evidence
Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation. |
| 34 | NordSpace lowweak | Opp 2 Risk 4 | Thesis: Main risk is evidence insufficiency and likely execution uncertainty around an early-stage space venture rather than confirmed adverse developments; the reviewed sources contain no available direct negative evidence within the recent evidence window and no current dated business-state confirmation, unavailable in reviewed sources). Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources. Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources. |
| 35 | NorthStar Earth & Space Inc. lowweak | Opp 2 Risk 4 | Thesis: This row carries elevated information risk because the reviewed sources show no recently retained evidence, no representative articles, and no direct positive or negative evidence, while the ticker/public status implications are time-sensitive and unsupported here. Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources. Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments. |
| 36 | Northwood Space mediumweak | Opp 6 Risk 4 | Thesis: Risk is still moderate because the visible reviewed sources does not include the underlying article summary or, so the funding signal lacks fuller context such as use of proceeds, valuation, or milestone cadence. Why now: The rationale references article: and states Northwood Space raised $100 million in a notable spacetech funding deal; that size of financing is plausibly durable over a 1 year+ horizon, though recency cannot be fully validated from the absent article body. Caveats: No representative article or provided in the visible evidence body. No direct evidence after recent evidence window are exposed despite the positive rationale. Funding alone does not prove technical or commercial execution. |
| 37 | Obruta Space Solutions lowweak | Opp 4 Risk 4 | Thesis: Current risk is equal to opportunity because the reviewed sources only shows descriptive company-site context and no direct evidence of contracts, funding, launches, or technical milestones. Without validation, the thesis is still conceptual. Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year. Evidence
Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown. |
| 38 | Observable Space lowweak | Opp 4 Risk 4 | Thesis: The reviewed sources provide no direct operating-niche detail, traction, or milestone evidence beyond the funding mention, so execution risk is relatively elevated despite the financing signal. Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence. Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without. |
| 39 | Observable Space mediummedium | Opp 8 Risk 4 | Thesis: Risk remains meaningful because most evidence is supporting source context and neutral facts rather than explicit positive events, and the company still appears to be early-stage, contract-execution dependent, and private. Why now: The timing is favorable because on May 28, 2026 the company was reported to have both closed a $90 million Series A and announced a $94 million U.S. Space Force award, with additional follow-on reporting on June 9, 2026 indicating the contract landed just weeks after the raise, suggesting a recent step-change in funding and government traction for a 1 year+ horizon Evidence
Caveats: Positive direction is inferred from neutral facts plus article summaries; the reviewed sources does not provide explicit positive events. Same-article repeated rows are not independent confirmation. Supporting web-search evidence is context and should be treated below directly cited company evidence. |
| 40 | OMSPACE lowweak | Opp 4 Risk 4 | Thesis: Launch development risk is also high because the evidence only shows an early milestone and a future plan for orbital launch capability by 2027. The reviewed sources contain no retained proof of financing, customer backlog, or follow-on technical milestones, so execution risk is substantial. Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment. Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced. |